Feedback / Questions
inupadenant (EOS-850) - iTeos
https://www.globenewswire.com/news-release/2024/12/12/2996233/0/en/iTeos-Therapeutics-Presents-Interim-A2A-005-Clinical-Trial-Data-Translational-and-Preclinical-Data-from-Inupadenant-at-ESMO-Immuno-Oncology-Congress.html
Dec 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next